UBS Maintains Neutral on Corteva, Lowers Price Target to $86
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $90 to $86.
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $90 to $86.